Gino In

Title	Assistant Professor of Clinical Medicine
Institution	University of Southern California
Department	Medicine
Address	GNH 3821 Health Sciences Campus Los Angeles CA 90089-9324
Phone	+1 323 226 7622
vCard	Download vCard

Biography

Education and Training

University of Southern California, Los Angeles, CA	Fellowship	2016	Hematology/Oncology
SUNY Downstate Medical Center, Brooklyn, NY	Residency	2011	Internal Medicine
SUNY Downstate Medical Center, Brooklyn, NY	Internship	2010
Ross University, North Brunswick Township, NJ	MD	2010	Medicine
Emory University, Atlanta, GA	MPH	2006	Environmental/Occupational Health
Emory University, Atlanta, GA	BS	2002

Awards and Honors

University of Southern California

Chief Medical Oncology Fellow

Overview

Gino K. In is a medical oncologist who specializes in solid tumor and cutaneous oncology. He completed his residency training in hematology and oncology at the University of Southern California Keck School of Medicine, where he was the chief medical oncology fellow. He has stayed on to serve as Assistant Professor of Medicine in the Division of Oncology.

Dr. In’s research focus includes the multi-disciplinary management of melanoma and other skin cancers, with a specific interest in improving cancer outcomes among underserved populations, including adolescents and young adults, and Hispanics. He is actively involved with the USC Adolescent and Young Adult (AYA) Oncology Group, the USC Skin Cancer Task Force, and the Melanoma Prevention Working Group.

Interests

Medical Oncology, Skin Cancer, Melanoma, Acral Lentiginous Melanoma, Uveal Melanoma, Mucosal Melanoma, Squamous Cell Carcinoma, Basal Cell Carcinoma, Merkel Cell Carcinoma, Dermatofibrosarcoma Protuberans, Porocarcinoma

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.

List All | Timeline

Lara KM, In GK, Matcuk GR, Mehta A, Hu JS. Talimogene laherparepvec in combination with pembrolizumab leads to a complete response in a patient with refractory Merkel cell carcinoma. JAAD Case Rep. 2018 Nov; 4(10):1004-1006. PMID: 30450405.

View in: PubMed
Nazemi A, Higgins S, Swift R, In G, Miller K, Wysong A. Eccrine Porocarcinoma: New Insights and a Systematic Review of the Literature. Dermatol Surg. 2018 Jun 08. PMID: 29894433.

View in: PubMed
In G, Mason J, Lin S, Newton PK, Kuhn P, Nieva J. Development of metastatic brain disease involves progression through lung metastases in EGFR mutated non-small cell lung cancer. Converg Sci Phys Oncol. 2017 Sep; 3(3). PMID: 30283700.

View in: PubMed
In GK, Mason J, Lin S, Newton P, Kuhn P, Nieva J.Development of metastatic brain disease involves progression through lung metastases in EGFR mutated non-small cell lung cancer. Convergent Science Physical Oncology. 2017; 3(3).
Miller KA, In GK, Jiang SY, Ahadiat O, Higgins S, Wysong A, Cockburn MG.Skin Cancer Prevention Among Hispanics: a Review of the Literature. Epidemiology. 2017.
In GK, Hu JS, Tseng WW. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations. Ther Adv Med Oncol. 2017 Aug; 9(8):533-550. PMID: 28794805.

View in: PubMed
In GK, Nieva J.Emerging Chemotherapy Agents in Lung Cancer: Nanoparticle Therapeutics for Non-Small Cell Lung Cancer. Transl Cancer Res. 2015; 4(4):340-355.

View Publication
In G, Dorff T. Chemotherapy for Good-Risk Nonseminomatous Germ Cell Tumors: Current Concepts and Controversies. Urol Clin North Am. 2015 Aug; 42(3):347-57. PMID: 26216822.

View in: PubMed